DHG Pharmaceutical JSC Cash Flow-to-Debt Ratio
DHG Pharmaceutical JSC cash flow-to-debt ratio. DHG Pharmaceutical JSC (DHG) has a Cash Flow-to-Debt Ratio of 0.13x as of June 2026, meaning its operating cash flow of ₫214.23 Billion could theoretically repay 0% of its total liabilities (₫1.59 Trillion) in one year. Check DHG cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of DHG Pharmaceutical JSC (2019–2025)
Cash flow-to-debt ratio of DHG Pharmaceutical JSC from 2019 to 2025. Historical debt coverage capacity for DHG Pharmaceutical JSC across 7 annual periods. Check DHG cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
DHG Pharmaceutical JSC Cash Flow-to-Debt Ratio by Year (2019–2025)
DHG Pharmaceutical JSC cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for DHG Pharmaceutical JSC. For the full cash flow conversion analysis, see DHG Pharmaceutical JSC operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (VND) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | ₫1.21 Trillion | ₫983.26 Billion | ▲ +74.6% |
| 2024 | 0.71x | ₫1.32 Trillion | ₫1.86 Trillion | ▲ +217.5% |
| 2023 | 0.22x | ₫279.88 Billion | ₫1.26 Trillion | ▼ -78.4% |
| 2022 | 1.03x | ₫901.28 Billion | ₫876.65 Billion | ▲ +87.4% |
| 2021 | 0.55x | ₫452.44 Billion | ₫824.52 Billion | ▼ -41.6% |
| 2020 | 0.94x | ₫826.17 Billion | ₫879.46 Billion | ▼ -13.8% |
| 2019 | 1.09x | ₫838.24 Billion | ₫769.27 Billion | — |